Home » EUA Ebola Assays Compared in Head-to-Head Analysis; BioFire Test Deemed Advantageous

EUA Ebola Assays Compared in Head-to-Head Analysis; BioFire Test Deemed Advantageous

Jul 10, 2015

NEW YORK (GenomeWeb) – A newly published study has attempted to rigorously evaluate a few of the assays recently granted Emergency Use Authorization by the US Food and Drug Administration to test for Ebola Zaire virus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

This Week in Science

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

What's Popular?

In PCR

  1. Myriad Genetics' Breast Cancer Recurrence Test Wins Positive Coverage From Palmetto, Anthem

  2. Single-Color Digital PCR Method Shows Promise for Blood-Based Cancer Monitoring

    Premium

  3. Heart Disease Risk Alleles Reported In 17th Century Korean Mummy

  4. Diagenode to Commercialize Clinical Breast Cancer Test Based on New Epigenetic Signature

    Premium

  5. FDA Grants EUA for Columbia University's Zika Test

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.